Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Other Working Capital Changes of -$46000.0 in Q3 2025, down 866.67% quarter-over-quarter from $6000.0 in Q2 2025, and down 112.43% on a YoY basis from $370000.0 in Q3 2024.
Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$46000.0 for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 112.43% year-over-year to -$46000.0; the TTM figure through Sep 2025 stood at -$74000.0 (up 69.17% YoY), while the FY2024 annual figure was $5000.0, up 101.38% from the prior year.
- Other Working Capital Changes was -$46000.0 for Q3 2025 at Cyclerion Therapeutics, down from $6000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $461000.0 in Q4 2022 to a low of -$1.1 million in Q2 2021.
- Historically, Other Working Capital Changes has averaged -$85750.0 across 5 years, with a median of -$36500.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 477.78% in 2023, then jumped 216.35% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$1.1 million in 2021, then surged by 140.44% to $461000.0 in 2022, then slumped by 161.61% to -$284000.0 in 2023, then jumped by 86.27% to -$39000.0 in 2024, then dropped by 17.95% to -$46000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$46000.0 (Q3 2025), $6000.0 (Q2 2025), and $5000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -46,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -39,000.00 |
| Dec 31, 2024 | -39,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Jun 30, 2024 | -326,000.00 |
| Jun 30, 2024 | -326,000.00 |
| Dec 31, 2023 | -284,000.00 |
| Dec 31, 2023 | -284,000.00 |
| Sep 30, 2023 | -318,000.00 |
| Sep 30, 2023 | -318,000.00 |
| Jun 30, 2023 | 273,000.00 |
| Jun 30, 2023 | 273,000.00 |
| Mar 31, 2023 | -34,000.00 |
| Mar 31, 2023 | -34,000.00 |